Kentucky Lawmakers Push Bill Regulating THC-Infused Beverages Like Alcohol
Kentucky is advancing legislation focused on THC beverage regulations to mirror alcohol oversight. These regulations address unique dosing and safety risks of THC-infused drinks. Clinicians must understand these changes to provide accurate patient…
Optimizing Cannabis Dosing Protocols: Benefits and Risks
Cannabis dosing protocols are essential for maximizing medical benefits while reducing adverse effects. Understanding the THC-to-CBD ratio helps personalize treatment and improve safety. Clinicians should adopt careful titration strategies to optimize…
Cannabinoids in Children: Medical Evidence Reviewed
Cannabinoids in pediatric medicine have been studied for various medical conditions with emerging clinical evidence. This review highlights safety and therapeutic applications in children. Clinicians must weigh benefits and risks carefully when…
Someones gotta do it!
Someone has to conduct the rigorous clinical trials, and it turns out that responsibility comes with surprisingly thorough documentation requirements. The peer review process is significantly less forgiving than most institutional review boards. Via…
Ohio Brewing Companies Challenge Hemp THC Beverage Ban
The focus on hemp-derived THC beverages legal status is critical as Ohio brewing companies sue to keep these products accessible. This legal dispute highlights regulatory uncertainty affecting patient access to cannabinoid beverages. Clinicians must…
Roseburg Cannabis Expert Explains Clinical Differences Between THC and CBD
Understanding the clinical differences between THC and CBD is essential for accurate patient counseling. THC produces psychoactive effects while CBD offers therapeutic benefits with minimal abuse risk. This knowledge helps clinicians guide patients in…
Medicare’s CBD Gamble: Is Washington About to Bypass FDA Drug Approval?
Medicare CBD coverage policy may bypass FDA drug approval, raising concerns about product quality and safety. Clinicians face challenges due to uncertain dosing and evidence standards. This regulatory shift could impact patient care and clinical…
Differentiation of Cannabinoid Isomers via Cu‐Mediated Molecular Ion Formation
Cannabinoid isomer differentiation is essential for clinical safety and accurate product labeling. This study introduces a copper-mediated method to reliably distinguish cannabinoid isomers. Improved differentiation supports better clinical…
Veterans Push Congress on Cannabis & Psychedelics Access (Newsletter: March 9, 2026)
The veterans medical cannabis amendment is gaining momentum in Congress, reflecting growing advocacy for expanded access. Clinicians treating veterans must stay informed about evolving policies on cannabis and psychedelics access. This amendment could…
Regulatory Digest 2026-03-09
Regulatory updates (higher clinical relevance)
